Featured news, clinical trials, MSU updates and more.
, , Dermatomyositis, Featured, News
The research found that DM patients with the anti-transcriptional intermediary factor 1 (anti-TIF1) antibody were more than three times...
The authors propose that a new classification system for Idiopathic Inflammatory Myopathies (IIM) based on phenotypic (observable characteristics), biologic...
MSU is just getting started. You see, as long as there are still people dying from the various myositis...
, , Featured, News
Clinical trials and studies require patient groups in clearly defined categories, but the multiple diagnostic and classification criteria used...
, , Featured, Inclusion Body Myositis (IBM)
The purpose of this article is to describe advancements in the diagnosis of Inclusion Body Myositis (IBM) and therapy...
Updated April 23, 2019 - Study is fully enrolled. One of our goals is to provide inclusion body...
, , Featured, News
In this study, the researchers set out to determine if there was a distinction between the type of autoantibodies...
, , Featured, Necrotizing Autoimmune Myopathy
Statins are drugs that lower cholesterol. There have been reports indicating that statin use may be associated with idiopathic...
Corbus Pharmaceuticals announced today that they will proceed with a Phase 3 clinical trial to evaluate the efficacy and...
Explaining myositis (Idiopathic Inflammatory Myopathy) and how it affects our lives is difficult. There isn’t a simple, clear-cut answer...
, , Featured, Personal Stories
May is both Myositis and Mental Health Awareness Month and Jerry Williams, Founder and President of MSU shares the...
Earn donations to Myositis Support and Understanding Association at no added cost to you by using goodshop.
© 2025 Myositis Support and Understanding Association (MSU). All rights reserved. | View our Privacy Policy, Terms, and Non-Discrimination policy. MSU is a charitable organization with 501(c)(3) tax-exempt status. Federal ID #47-4570748.
